Experts publish 37 recommendations for rare genetic disorder management
The study provides new guidance for treating cleidocranial dysplasia, a condition affecting approximately one in a million people.
A multidisciplinary panel of 13 experts has established 37 consensus recommendations for the diagnosis, treatment, and long-term management of cleidocranial dysplasia (CCD), according to a Times of India report.
The research, published in the Journal of Bone and Mineral Research on January 8, 2026, involved specialists from CCD Smiles, Johns Hopkins, and other institutions.
CCD is a rare genetic disorder that affects bone and teeth development, often causing missing collarbones, skull complications, and dental issues.
The study includes nine recommendations for diagnosis, 24 for treatment and management, and four regarding healthcare providers.
The guidance suggests children with the condition should have orthodontic screening by age six and recommends regular dental monitoring through X-rays.
Medical experts also advised annual hearing assessments and regular orthopaedic evaluations to monitor bone density and potential fractures.
The research was supported by CCD Smiles, a nonprofit organisation that actor Gaten Matarazzo and his family helped formally establish in January 2017.
Matarazzo, who has the condition, previously told Cero Magazine in November 2025 that patients often relied on doctors with limited experience treating the disorder.